Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia

We describe an 81-year-old relapsed acute promyelocytic leukemia hemodialysis-dependent patient with a pre-existing cardiac condition who was treated with 10 mg arsenic trioxide three times weekly after dialysis. These findings provide support along with the marginal amount of currently published data for an arsenic trioxide dosing regimen in hemodialysis patients.

http://opp.sagepub.com/cgi/content/abstract/22/4/646?rss=1

Source: Journal of Oncology Pharmacy Practice - June 20, 2016 Category: Cancer & Oncology Authors: Perreault, S., Moeller, J., Patel, K., Eyler, R., Pham, T., Russell, K., Podoltsev, N. Tags: Case Reports Source Type: research